Bioequivalence Study of Gefitinib Tablets Under Fed Conditions
NCT03050177
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Gefitinib Tablet 250mg of Hunan Kelun
DRUG:
Iressa® Tablet 250mg of AZN
Sponsor
Hunan Kelun Pharmaceutical Co., Ltd.